Antitumor IgE adjuvanticity: Key role of FcεRI

Journal of Immunology

Volumn 183, Issue 7, 2009, Pages 4530-4536

  Nigro, Elisa A ^a,b   Brini, Anna T ^a   Soprana, Elisa ^b   Ambrosi, Alessandro ^b   Dombrowicz, David ^c   Siccardi, Antonio G ^a,b   Vangelista, Luca ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD23 ANTIGEN; FC EPSILON RECEPTOR RI; FC RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; TUMOR VACCINE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CANCER VACCINE; CROSS LINKING REAGENT; IMMUNOLOGICAL ADJUVANT; TUMOR ANTIGEN;

ADAPTIVE IMMUNITY; ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; BREAST ADENOCARCINOMA; CELL KILLING; CONTROLLED STUDY; CROSS PRESENTATION; EFFECTOR CELL; EOSINOPHIL; FEMALE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT; T CELL LYMPHOMA; T LYMPHOCYTE; TUMOR CELL; TUMOR IMMUNITY; VACCINIA VIRUS; ADENOCARCINOMA; ANIMAL; C57BL MOUSE; EXPERIMENTAL NEOPLASM; GENE TARGETING; GENETICS; HUMAN; IMMUNOLOGY; MAST CELL LEUKEMIA; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE; TUMOR CELL LINE;

ADENOCARCINOMA; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; CANCER VACCINES; CELL LINE, TUMOR; CROSS-LINKING REAGENTS; FEMALE; GENE KNOCK-IN TECHNIQUES; HUMANS; IMMUNOGLOBULIN E; LEUKEMIA, BASOPHILIC, ACUTE; LYMPHOMA, T-CELL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RATS; RECEPTORS, IGE;

EID: 70449732758     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900842     Document Type: Article

References (48)

1. Gould, H. J., and B. J. Sutton. 2008. IgE in allergy and asthma today. Nat. Rev. Immunol. 8: 205-217.
2. Gergen, P. J., P. C. Turkeltaub, and C. T. Sempos. 2000. Is allergen skin test reactivity a predictor of mortality? Findings from a national cohort. Clin. Exp. Allergy 30: 1717-1723.
3. Turner, M. C., Y. Chen, D. Krewski, and P. Ghadirian. 2006. An overview of the association between allergy and cancer. Int. J. Cancer 118: 3124-3132.
4. Merrill, R. M., R. T. Isakson, and R. E. Beck. 2007. The association between allergies and cancer: what is currently known? Ann. Allergy Asthma Immunol. 99: 102-116.
5. Holly, E. A., C. A. Eberle, and P. M. Bracci. 2003. Prior history of allergies and pancreatic cancer in the San Francisco Bay area. Am. J. Epidemiol. 158: 432-441.
6. Gandini, S., A. B. Lowenfels, E. M. Jaffee, T. D. Armstrong, and P. Maisonneuve. 2005. Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanisms. Cancer Epidemiol. Biomarkers Prev. 14: 1908-1916. (Pubitemid 41161199)
7. Eppel, A., M. Cotterchio, and S. Gallinger. 2007. Allergies are associated with reduced pancreas cancer risk: a population-based case-control study in Ontario, Canada. Int. J. Cancer 121: 2241-2245. (Pubitemid 47585604)
8. Wen, W., X. O. Shu, M. S. Linet, J. P. Neglia, J. D. Potter, M. E. Trigg, and L. L. Robison. 2000. Allergic disorders and the risk of childhood acute lymphoblastic leukemia (United States). Cancer Causes Control. 11: 303-307. (Pubitemid 30255872)
9. Schuz, J., G. Morgan, E. Bohler, P. Kaatsch, and J. Michaelis. 2003. Atopic disease and childhood acute lymphoblastic leukemia. Int. J. Cancer 105: 255-260. (Pubitemid 36505330)
10. Brenner, A. V., M. S. Linet, H. A. Fine, W. R. Shapiro, R. G. Selker, P. M. Black, and P. D. Inskip. 2002. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int. J. Cancer 99: 252-259.
11. Wiemels, J. L., J. K. Wiencke, J. D. Sison, R. Miike, A. McMillan, and M. Wrensch. 2002. History of allergies among adults with glioma and controls. Int. J. Cancer 98: 609-615.
12. Wrensch, M., J. K. Wiencke, J. Wiemels, R. Miike, J. Patoka, M. Moghadassi, A. McMillan, K. T. Kelsey, K. Aldape, K. R. Lamborn, et al. 2006. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res. 66: 4531-4541.
13. Mills, P. K., W. L. Beeson, G. E. Fraser, and R. L. Phillips. 1992. Allergy and cancer: organ site-specific results from the Adventist Health Study. Am. J. Epidemiol. 136: 287-295.
14. Nagy, E., I. Berczi, and A. H. Sehon. 1991. Growth inhibition of murine mammary carcinoma by monoclonal IgE antibodies specific for the mammary tumor virus. Cancer Immunol. Immunother. 34: 63-69.
15. Kershaw, M. H., P. K. Darcy, J. A. Trapani, D. MacGregor, and M. J. Smyth. 1998. Tumor- specific IgE-mediated inhibition of human colorectal carcinoma xenograft growth. Oncol. Res. 10: 133-142.
16. Gould, H. J., G. A. Mackay, S. N. Karagiannis, C. M. O'Toole, P. J. Marsh, B. E. Daniel, L. R. Coney, V. R. Zurawski, Jr., M. Joseph, M. Capron, et al. 1999. Comparison of IgE and IgG antibody-dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinoma. Eur. J. Immunol. 29: 3527-3537.
17. Miotti, S., S. Canevari, S. Ménard, D. Mezzanzanica, G. Porro, S. M. Pupa, M. Regazzoni, E. Tagliabue, and M. I. Colnaghi. 1987. Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity. Int. J. Cancer 39: 297-303. (Pubitemid 17038183)
18. Coney, L. R., A. Tomassetti, L. Carayannopoulos, V. Frasca, B. A. Kamen, M. I. Colnaghi, and V. R. Zurawski, Jr. 1991. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. Cancer Res. 51: 6125-6132.
19. Karagiannis, S. N., Q. Wang, N. East, F. Burke, S. Riffard, M. G. Bracher, R. G. Thompson, S. R. Durham, L. B. Schwartz, F. R. Balkwill, and H. J. Gould. 2003. Activity of human monocytes in IgE antibody-dependent surveillance and killing of ovarian tumor cells. Eur. J. Immunol. 33: 1030-1040.
20. Karagiannis, S. N., M. G. Bracher, J. Hunt, N. McCloskey, R. L. Beavil, A. J. Beavil, D. J. Fear, R. G. Thompson, N. East, F. Burke, et al. 2007. IgEantibody- dependent immunotherapy of solid tumors: cytotoxic and phagocytic mechanisms of eradication of ovarian cancer cells. J. Immunol. 179: 2832-2843.
21. Karagiannis, S. N., M. G. Bracher, R. L. Beavil, A. J. Beavil, J. Hunt, N. McCloskey, R. G. Thompson, N. East, F. Burke, B. J. Sutton, et al. 2008. Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells. Cancer Immunol. Immunother. 57: 247-263.
22. Untersmayr, E., I. Scholl, I. Swoboda, W. J. Beil, E. Förster-Waldl, F. Walter, A. Riemer, G. Kraml, T. Kinaciyan, S. Spitzauer, et al. 2003. Antacid medication inhibits digestion of dietary proteins and causes food allergy: a fish allergy model in BALB/c mice. J. Allergy Clin. Immunol. 112: 616-623.
23. Scholl, I., E. Untersmayr, N. Bakos, M. Kundi, F. Roth-Walter, K. Szalai, A. B. Riemer, H. J. Ankersmit, O. Scheiner, G. Boltz-Nitulescu, and E. Jensen-Jarolim. 2005. Antiulcer drugs promote oral sensitization and hypersensitivity to hazelnut allergens in BALB/c mice and humans. Am. J. Clin. Nutr. 81: 154-160.
24. Riemer, A. B., E. Untersmayr, R. Knittelfelder, A. Duschl, H. Pehamberger, C. C. Zielinski, O. Scheiner, and E. Jensen-Jarolim. 2007. Active induction of tumor-specific IgE antibodies by oral mimotope vaccination. Cancer Res. 67: 3406-3411.
25. Reali, E., J. W. Greiner, A. Corti, H. J. Gould, F. Bottazzoli, G. Paganelli, J. Schlom, and A. G. Siccardi. 2001. IgEs targeted on tumor cells: therapeutic activity and potential in the design of tumor vaccines. Cancer Res. 61: 5517-5522.
26. Dombrowicz, D., V. Flamand, K. K. Brigman, B. H. Koller, and J. P. Kinet. 1993. Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α chain gene. Cell 75: 969-976.
27. Yu, P., M. Kosco-Vilbois, M. Richards, G. Kohler, and M. C. Lamers. 1994. Negative feedback regulation of IgE synthesis by murine CD23. Nature 369: 753-756. (Pubitemid 24225366)
28. Dombrowicz, D., A. T. Brini, V. Flamand, E. Hicks, J. N. Snouwaert, J. P. Kinet, and B. H. Koller. 1996. Anaphylaxis mediated through a humanized high affinity IgE receptor. J. Immunol. 157: 1645-1651. (Pubitemid 126449106)
29. Wiegand, T. W., P. B. Williams, S. C. Dreskin, M. H. Jouvin, J. P. Kinet, and D. Tasset. 1996. High-affinity oligonucleotide ligands to human IgE inhibit binding to Fcε receptor I. J. Immunol. 157: 221-230. (Pubitemid 26190551)
30. Vangelista, L., E. Soprana, M. Cesco-Gaspere, P. Mandiola, G. Di Lullo, R. N. Fucci, F. Codazzi, A. Palini, G. Paganelli, O. R. Burrone, and A. G. Siccardi. 2005. Membrane IgE binds and activates FcεRI in an antigen-independent manner. J. Immunol. 174: 5602-5611.
31. Gasparri, A., M. Moro, F. Curnis, A. Sacchi, S. Pagano, F. Veglia, G. Casorati, A. G. Siccardi, P. Dellabona, and A. Corti. 1999. Tumor pretargeting with avidin improves the therapeutic index of biotinylated tumor necrosis factor α in mouse models. Cancer Res. 59: 2917-2923.
32. Pinheiro, J. C., and D. M. Bates. 2000. Mixed-effects models in S and S-PLUS. In Statistics and Computing Series. J. Chambers, D. J. Hand, W. K. Härdle, eds. Springer-Verlag, New York, NY.
33. Yang, L., N. Yamagata, R. Yadav, S. Brandon, R. L. Courtney, J. D. Morrow, Y. Shyr, M. Boothby, S. Joyce, D. P. Carbone, and R. M. Breyer. 2003. Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor. J. Clin. Invest. 111: 727-735.
34. Sun, S., C. T. Ting, and C. I. Wu. 2004. The normal function of a speciation gene, Odysseus, and its hybrid sterility effect. Science 305: 81-83.
35. Goddard, M. R., H. C. Godfray, and A. Burt. 2005. Sex increases the efficacy of natural selection in experimental yeast populations. Nature 434: 636-640.
36. Howard, R. J., E. Juszczak, C. G. Ballard, P. Bentham, R. G. Brown, R. Bullock, A. S. Burns, C. Holmes, R. Jacoby, T. Johnson, et al. 2007. Donepezil for the treatment of agitation in Alzheimer's disease. N. Engl. J. Med. 357: 1382-1392.
37. Skvara, H., M. Dawid, E. Kleyn, B. Wolff, J. G. Meingassner, H. Knight, T. Dumortier, T. Kopp, N. Fallahi, G. Stary, et al. 2008. The PKC inhibitor AEB071 may be a therapeutic option for psoriasis. J. Clin. Invest. 118: 3151-3159.
38. Claman, H. N., and S. D. Miller. 1976. Requirements for induction of T cell tolerance to DNFB: efficiency of membrane-associated DNFB. J. Immunol. 117: 480-485.
39. Meyer, H., G. Sutter, and A. Mayr. 1991. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. J. Gen. Virol. 72: 1031-1038.
40. Acres, B., and J. Y. Bonnefoy. 2008. Clinical development of MVA-based therapeutic cancer vaccines. Expert Rev. Vaccines 7: 889-893.
41. Benigni, F., V. S. Zimmermann, S. Hugues, S. Caserta, V. Basso, L. Rivino, E. Ingulli, L. Malherbe, N. Glaichenhaus, and A. Mondino. 2005. Phenotype and homing of CD4 tumor-specific T cells is modulated by tumor bulk. J. Immunol. 175: 739-748.
42. Kinet, J. P. 1999. The high-affinity IgE receptor (FcεRI): from physiology to pathology. Annu. Rev. Immunol. 17: 931-972.
43. Jensen-Jarolim, E., G. Achatz, M. C. Turner, S. Karagiannis, F. Legrand, M. Capron, M. L. Penichet, J. A. Rodríguez, A. G. Siccardi, L. Vangelista, et al. 2008. AllergoOncology: the role of IgE-mediated allergy in cancer. Allergy 63: 1255-1266.
44. Fu, S. L., J. Pierre, T. A. Smith-Norowitz, M. Hagler, W. Bowne, M. R. Pincus, C. M. Mueller, M. E. Zenilman, and M. H. Bluth. 2008. Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells. Clin. Exp. Immunol. 153: 401-409.
45. Rosato, A., S. Dalla Santa, A. Zoso, S. Giacomelli, G. Milan, B. Macino, V. Tosello, P. Dellabona, P. L. Lollini, C. De Giovanni, and P. Zanovello. 2003. The cytotoxic T- lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus. Cancer Res. 63: 2158-2163.
46. Kayaba, H., D. Dombrowicz, G. Woerly, J. P. Papin, S. Loiseau, and M. Capron. 2001. Human eosinophils and human high affinity IgE receptor transgenic mouse eosinophils express low levels of high affinity IgE receptor, but release IL-10 upon receptor activation. J. Immunol. 167: 995-1003.
47. Dombrowicz, D., S. Lin, V. Flamand, A. T. Brini, B. H. Koller, and J. P. Kinet. 1998. Allergy-associated FcRβ is a molecular amplifier of IgE- and IgG-mediated in vivo responses. Immunity 8: 517-529.
48. Vangelista, L. 2003. Current progress in the understanding of IgE-FcεRI interaction. Int. Arch. Allergy Immunol. 131: 222-233.